More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

A New York official rejected Texas's latest attempt to penalize a doctor who allegedly prescribed abortion pills to a Dallas woman - the latest clash in a legal battle expected to make its way to the ...

Texas lawmakers will return to the dome in Austin Monday with a laundry list of priorities from Governor Abbott.